Rockbridge Investment Management’s AbbVie ABBV Stock Holding History

Rockbridge Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-341	Closed	-$52.8K	–	123
2023 Q4	$52.8K	Buy	+341	New	+$49.7K	0.01%	236
2023 Q1	–	Sell	-1,359	Closed	-$220K	–	109
2022 Q4	$220K	Buy	+1,359	New	+$208K	0.04%	101
2022 Q3	–	Sell	-816	Closed	-$125K	–	104
2022 Q2	$125K	Sell	816 -222	-21%	-$33.9K	0.03%	133
2022 Q1	$169K	Sell	1,038 -233	-18%	-$33.8K	0.03%	174
2021 Q4	$172K	Buy	1,271 +96	+8%	+$11.3K	0.03%	194
2021 Q3	$127K	Buy	1,175 +5	+0.4%	+$571	0.02%	202
2021 Q2	$132K	Buy	1,170 +70	+6%	+$7.88K	0.02%	195
2021 Q1	$119K	Sell	1,100 -11	-1%	-$1.18K	0.02%	190
2020 Q4	$119K	Buy	1,111 +506	+84%	+$48.6K	0.02%	183
2020 Q3	$53K	Sell	605 -125	-17%	-$11.8K	0.01%	259
2020 Q2	$72K	Buy	+730	New	+$64.3K	0.02%	200

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Rockbridge Investment Management's ABBV Position: Q1 2024 in Review

Rockbridge Investment Management sold out of AbbVie (ABBV) in Q1 2024, closing a stake of 341 shares — an estimated $52.8K sold.

Rockbridge Investment Management first reported a position in ABBV in Q2 2020 and held it in 11 quarters. The position peaked at $220K in Q4 2022. 3,380 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

Rockbridge Investment Management reported no remaining AbbVie position as of Q1 2024 after selling out during the quarter.
Rockbridge Investment Management sold 341 AbbVie shares in Q1 2024, an estimated $52.8K.
Rockbridge Investment Management first reported a position in AbbVie in Q2 2020 and held it in 11 quarters.
Rockbridge Investment Management's AbbVie position peaked at $220K in Q4 2022.
3,380 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on Rockbridge Investment Management's 13F filing for Q1 2024, filed 15 May 2024.